best performing large cap stock between may 2014 and oct 2015

Neurocrine Biosciences (NBIX) had the highest return between May 1, 2014 and October 31, 2015 by a large-cap US stock, returning 248.9%.

ASSET DATE % RETURN
Neurocrine Biosciences (NBIX)
5/1/2014 - 10/31/2015
248.9%
Coca-Cola Consolidated (COKE)
5/1/2014 - 10/31/2015
189.2%
DexCom (DXCM)
5/1/2014 - 10/31/2015
158.36%
Genmab A-S (GMAB)
5/1/2014 - 10/31/2015
158.18%
Electronic Arts (EA)
5/1/2014 - 10/31/2015
153.05%
Palo Alto Networks (PANW)
5/1/2014 - 10/31/2015
151.96%
Paycom Soft (PAYC)
5/1/2014 - 10/31/2015
148.59%
Incyte (INCY)
5/1/2014 - 10/31/2015
148.37%
Netflix (NFLX)
5/1/2014 - 10/31/2015
134.12%
Manhattan Associates (MANH)
5/1/2014 - 10/31/2015
132.15%
Celsius (CELH)
5/1/2014 - 10/31/2015
131.3%
Comfort Systems USA (FIX)
5/1/2014 - 10/31/2015
128.67%
NetEase (NTES)
5/1/2014 - 10/31/2015
115.78%
Tyler Technologies (TYL)
5/1/2014 - 10/31/2015
107.91%
Amazon (AMZN)
5/1/2014 - 10/31/2015
105.8%
Global Payments (GPN)
5/1/2014 - 10/31/2015
103.89%
Monster Beverage (MNST)
5/1/2014 - 10/31/2015
103.28%
Biomarin Pharmaceutical (BMRN)
5/1/2014 - 10/31/2015
102.18%
Trip Group Ltd ADR (TCOM)
5/1/2014 - 10/31/2015
100.32%
Broadcom (AVGO)
5/1/2014 - 10/31/2015
99.69%
Ulta Beauty (ULTA)
5/1/2014 - 10/31/2015
98.58%
CyberArk Software (CYBR)
5/1/2014 - 10/31/2015
98.56%
Advanced Drainage Systems (WMS)
5/1/2014 - 10/31/2015
97.09%
Norwegian Cruise Line (NCLH)
5/1/2014 - 10/31/2015
94.08%
Southwest Airlines (LUV)
5/1/2014 - 10/31/2015
93.61%
Large-cap stocks are treated as having a market cap of $10B+.